BRUSSELS (Reuters) – A trade war with the United States could have a fleeting impact on euro zone inflation but a far more detrimental effect
Category: Economy
Ambitious climate action could boost global 2040 GDP by 0.2%, says OECD study
By Riham Alkousaa BERLIN (Reuters) – Accelerated climate action could boost global GDP by 0.2% by 2040 compared with current policies, a study showed on
Mining, defence stocks lift UK shares after volatile week
(Reuters) – British stocks rose on Friday, driven by gains in defence and mining stocks, after a chopppy week filled with uncertainty around U.S. tariffs.
Column-Trump tariffs won’t easily derail euro zone recovery, says Klement
By Joachim Klement The euro zone is showing early signs of an economic recovery that is unlikely to be derailed by the tariffs the Trump
Russian rouble, stocks surge after Trump-Putin call
By Gleb Bryanski MOSCOW (Reuters) – The Russian rouble and stocks surged on Thursday after a telephone conversation between U.S. President Donald Trump and Russian
Foreigners add $19.2 billion to EM portfolios in November, IIF says
By Rodrigo Campos (Reuters) -Foreign investors added a net $19.2 billion to their emerging market portfolio holdings in November, with selling of stocks more than
American Tower misses quarterly revenue estimates on leasing slowdown
(Reuters) – Real estate investment trust American Tower missed estimates for third-quarter revenue on Tuesday due to diminished customer spending in its leasing business. The
Snap-On misses quarterly sales estimates on lower tool demand
(Reuters) – Snap-On posted a lower-than-expected third-quarter sales on Thursday, as inflationary pressures weighed on demand in the tools segment. Higher borrowing costs and a
Top BRICS economic officials stay away from Moscow meeting
By Gleb Bryanski MOSCOW (Reuters) – Most finance ministers and central bank chiefs from the BRICS group of countries did not attend a high-level meeting
Mpox-linked stocks extend rally into second week
(Reuters) – Shares of some mpox vaccine and drug developers jumped sharply on Monday in premarket trading, putting them on track to extend gains from